Cannabinoid Receptor Antagonists
"Cannabinoid Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit or block the activity of CANNABINOID RECEPTORS.
|Cannabinoid Receptor Antagonists
- Cannabinoid Receptor Antagonists
- Antagonists, Cannabinoid Receptor
- Receptor Antagonists, Cannabinoid
- Cannabinoid Receptor Blockers
- Blockers, Cannabinoid Receptor
- Receptor Blockers, Cannabinoid
- Cannabinoid Antagonists
- Antagonists, Cannabinoid
- Cannabinoid Blockers
- Blockers, Cannabinoid
Below are MeSH descriptors whose meaning is more general than "Cannabinoid Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Cannabinoid Receptor Antagonists".
This graph shows the total number of publications written about "Cannabinoid Receptor Antagonists" by people in this website by year, and whether "Cannabinoid Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Cannabinoid Receptor Antagonists" by people in Profiles.
Cannabinoid receptor type 1 antagonists alter aspects of risk/reward decision making independent of toluene-mediated effects. Psychopharmacology (Berl). 2022 May; 239(5):1337-1347.
Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity. Sci Rep. 2017 11 15; 7(1):15645.
Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism. Sci Rep. 2017 02 13; 7:42157.
Perinatal exposure to ?9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens. J Pharmacol Exp Ther. 2011 Nov; 339(2):607-17.
Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model. J Pharmacol Exp Ther. 2011 Sep; 338(3):819-28.
Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009 Oct; 1(7):1333-49.
Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology. 2005 Jun; 48(8):1105-16.